Oncology clinical trial design planning based on a multistate model that jointly models progression-free and overall survival endpoints
A Erdmann, J Beyersmann, K Rufibach - arXiv preprint arXiv:2301.10059, 2023 - arxiv.org
When planning an oncology clinical trial, the usual approach is to assume proportional
hazards and even an exponential distribution for time-to-event endpoints. Often, besides the …
hazards and even an exponential distribution for time-to-event endpoints. Often, besides the …